Research

Canadians spent more than $85 million on legal pot in May, an $11 million increase over April, on the back of new stores opening in Ontario and B.C.

Health Canada has only approved only 65 of approximately 600 cannabis research applications since legalization took place Oct. 17, according to a recent CTV News report.

Despite cannabis-infused beverages only making up around one per cent of sales in U.S. states with legal pot markets, BevCanna has high hopes for its CBD and THC-infused drinks.

The U.S. Food and Drug Administration (FDA) said last week it is speeding up its efforts to create rules for CBD and plans to publish a report on its progress by early fall.

U.S. cannabis market research firm Brightfield Group says the American CBD market will reach US$5 billion this year due to hemp legalization and more retail chains carrying CBD products.

Statistics Canada latest quarterly report from crowdsourced data showed a gram of legal pot costed $10.65 over the $5.93 price tag for illicit weed.

According to U.S. federal data, at the end of March there were 493 banks and 140 credit unions that handled transactions relating to the cannabis industry.

BDS Analytics and Arcview Market Research predict the global cannabis market will reach US$14.9 billion this year and US$40.6 billion by 2024.

Researchers found the number of U.S. high school students who said they used pot at least once a month jumped from 0.6 per cent in 1991 to 6.3 per cent in 2017.

National inventory levels of unfinished and unpackaged cannabis continued to rise in April, according to a report Health Canada released last month.

One-in-four medical cannabis users said supply issues have been preventing them from getting the medicine they need, according to a survey commissioned by Canadian Pharmacists Association and two other groups.

It took eight years and $83 million dollars for Tel Aviv-based Syqe Medical to develop the new product that will allow medical marijuana patients to take accurate doses.

Canopy Growth Corp. has been the cannabis industry's top dog by market capitalization so far, but U.S. companies are growing fast and could take over top spot.

Toronto-based CannaHorse announced Wednesday it launched the world's first-ever legal cannabis brand dedicated to horse health.

An annual report released by Ontario's ombudsman revealed that the OCS received the single most complaints among government organizations in the past year.

Next fall, the University of Maryland School of Pharmacy will offer a two-year master's program designed for health care practitioners, scientists, regulators, and industry professionals.

The Trudeau government said the money will be split between 13 different organizations across Canada to raise awareness on the harms associated with cannabis use.

More women are using marijuana during pregnancy in the U.S. and that might be causing health issues for their babies, two new studies suggest.

Parents and educators in the first U.S. states to legalize recreational cannabis are growing concerned about young people having increased access to highly potent pot.

Arcview Market Research and BDS Analytics forecast the legal industry will nearly triple by 2024 from the US$14.9 billion they project will be spent this year.

Canadian pot firms are amassing a supply glut of unfinished cannabis, and the issue could lead to industry writedowns, according to analysts at BMO Capital Markets.

Provincial and federal governments earned $186 million in total cannabis-related tax revenue in the first five-and-a-half months following legalization, according to new Statistics Canada data.

In a study at the Hebrew University of Jerusalem, researchers found rodents treated with a cannabinoid derived from cannabis had significantly better recoveries.

The Colorado Department of Revenue reported the landmark figure is comprised from marijuana taxes, licenses and fees on the state's total sales of US$6.5 billion since legalization began in 2014.

Advancing study into the substance is “something that wouldn't be possible in the prohibition era,” said Rebecca Haines-Saah of the University of Calgary.

The state known for its Rocky Mountains continues to set new heights with a record US$142 million in legal pot sales in March.

Despite encouraging results, researchers warned parents should wait for more data before they treat their children with autism.

Short supply, low quality, high prices, and long line ups at stores have plagued the legal market pushing almost 80 per cent of cannabis purchases to stay in the black market, according to data collected by Statistics Canada for the last quarter of 2018.

Statistics Canada released updated numbers for its National Cannabis Survey, which looked at usage during the first quarter of 2019. Here are the key takeaways from the report.

Massachusetts opened its doors to recreational marijuana back in November and we learned this week that it has now reached more than $100 million in sales according to the Cannabis Control Commission.

The State of Colorado recently updated its sales numbers for cannabis, and they're continuing to slide. With $119 million in sales for February, it was the lowest month that the State had since February of last year when it earned $113 million. It was also the second consecutive month that total cannabis sales were down.

Oregon has a marijuana supply problem. According to a report from the Oregon Liquor Control Commission, updated on March 2, there is nearly 1.2 million pounds of marijuana inventory sitting in the State in what it calls "usable marijuana."

With more recent data, the Canadian Cannabis market forecast has been cut by BDS Analytics.

Price is going to be a key determinant for recreational cannabis users to select legal pot over the supply that they can get from the black market. It's no wonder the black market is winning that battle in Canada right now.

Colorado Governor Jared Polis signed a bill that would allow medical marijuana use to be expanded to include autism as a qualifying medical condition.

As marijuana legalization has progressed in many parts of the world, cannabis companies have been working feverishly to expand and gain first-mover advantages in many emerging markets, could expanding into Europe this early be a mistake?

For all the hype that's been surrounding legalization in Canada, sales have slowed. Dried cannabis sales of 6,416 kg in October were impressive for a two-week period but that pace hasn't kept up. Here's a look.

Hexo Corp (TSX:HEXO) released its Q2 earnings this week in what the first full quarter of recreational sales. It was the first big test of the recreational market and it was definitely a big success. Sales of over $16 million dwarfed the $1 million in revenue that Hexo had earned a year ago. Even after excise, net revenues were still north of $13 million.